<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39377091</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2312-0541</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>ERJ open research</Title><ISOAbbreviation>ERJ Open Res</ISOAbbreviation></Journal><ArticleTitle>Assessing post-COVID-19 respiratory dynamics: a comprehensive analysis of pulmonary function, bronchial hyperresponsiveness and bronchodilator response.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">00149-2024</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/23120541.00149-2024</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Coronavirus disease 2019 (COVID-19) has a considerable impact on the global healthcare system. Individuals who have recovered from COVID often experience chronic respiratory symptoms that affect their daily lives. This study aimed to assess respiratory dynamics such as airway hyperresponsiveness (AHR) and bronchodilator response in post-COVID patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This study included 282 adults with respiratory symptoms who underwent provocation tests. The demographic details, clinical symptoms and medical histories were recorded. Baseline spirometry, methacholine challenge tests (MCT) and post-bronchodilator spirometry were performed. Patients were divided into the following four groups: Group 1: non-COVID-19 and negative MCT; Group 2: post-COVID-19 and negative MCT; Group 3: non-COVID-19 and positive MCT; and Group 4: post-COVID-19 and positive MCT.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Most post-COVID-19 patients (43.7%) experienced AHR, and wheezing was more common. Patients in Group 4 exhibited increased intensities of dyspnoea, cough and wheezing with the lowest pulmonary function test (PFT) parameters at baseline. Moreover, significant decreases in PFT parameters after the MCT were observed in these patients. Although the prevalence of a low forced expiratory volume in 1 s to forced vital capacity ratio (&lt;70%) was initially 2% in Group 4, it increased to 29% after MCT. No significant differences in allergic history or underlying diseases were observed between the groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">These findings provide comprehensive insights into the AHR and respiratory symptoms of post-COVID-19 individuals, highlighting the characteristics and potential exacerbations in patients with positive MCT results. This emphasises the need of MCT to address respiratory dynamics in post-COVID-19 individuals.</AbstractText><CopyrightInformation>Copyright ©The authors 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chun-Yao</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yao-Kuang</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Mei-Chen</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0002-6503-5189</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kuo-Liang</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Wen-Lin</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yi-Chih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chih-Wei</LastName><ForeName>Wu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzeng</LastName><ForeName>I-Shiang</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lan</LastName><ForeName>Chou-Chin</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ERJ Open Res</MedlineTA><NlmUniqueID>101671641</NlmUniqueID><ISSNLinking>2312-0541</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest: The authors have no potential conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39377091</ArticleId><ArticleId IdType="pmc">PMC11456966</ArticleId><ArticleId IdType="doi">10.1183/23120541.00149-2024</ArticleId><ArticleId IdType="pii">00149-2024</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cordova-Rivera L, Gibson PG, Gardiner PA, et al. . Physical activity and exercise capacity in severe asthma: key clinical associations. J Allergy Clin Immunol Pract 2018; 6: 814–822. doi: 10.1016/j.jaip.2017.09.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2017.09.022</ArticleId><ArticleId IdType="pubmed">29133222</ArticleId></ArticleIdList></Reference><Reference><Citation>Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet 2022; 399: 1513–1536. doi: 10.1016/s0140-6736(21)02796-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(21)02796-3</ArticleId><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson-Stuttard J, Caul S, McDonald S, et al. . Excess mortality in England post COVID-19 pandemic: implications for secondary prevention. Lancet Reg Health Eur 2024; 36: 100802. doi: 10.1016/j.lanepe.2023.100802</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100802</ArticleId><ArticleId IdType="pmc">PMC10769885</ArticleId><ArticleId IdType="pubmed">38188277</ArticleId></ArticleIdList></Reference><Reference><Citation>Assiri AM, Alamaa T, Elenezi F, et al. . Unveiling the clinical spectrum of post-COVID-19 conditions: assessment and recommended strategies. Cureus 2024; 16: e52827. doi: 10.7759/cureus.52827</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.52827</ArticleId><ArticleId IdType="pmc">PMC10884364</ArticleId><ArticleId IdType="pubmed">38406111</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortés-Telles A, López-Romero S, Figueroa-Hurtado E, et al. . Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol 2021; 288: 103644. doi: 10.1016/j.resp.2021.103644</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103644</ArticleId><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzam A, Khaled H, Refaey N, et al. . The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults. Virol J 2024; 21: 16. doi: 10.1186/s12985-024-02284-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-024-02284-3</ArticleId><ArticleId IdType="pmc">PMC10785462</ArticleId><ArticleId IdType="pubmed">38212781</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai DK, Sharma P, Karmakar S, et al. . Approach to post COVID-19 persistent cough: a narrative review. Lung India 2023; 40: 149–154. doi: 10.4103/lungindia.lungindia_250_22</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/lungindia.lungindia_250_22</ArticleId><ArticleId IdType="pmc">PMC10174656</ArticleId><ArticleId IdType="pubmed">37006099</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Lee H, Chung SJ, et al. . The usefulness of FEF(25-75) in predicting airway hyperresponsiveness to mannitol. J Asthma Allergy 2021; 14: 1267–1275. doi: 10.2147/jaa.S318502</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jaa.S318502</ArticleId><ArticleId IdType="pmc">PMC8560169</ArticleId><ArticleId IdType="pubmed">34737579</ArticleId></ArticleIdList></Reference><Reference><Citation>Virant FS, Randolph C, Nanda A, et al. . Pulmonary procedures during the COVID-19 pandemic: a work group report of the AAAAI Asthma Diagnosis and Treatment (ADT) interest section. J Allergy Clin Immunol Pract 2022; 10: 1474–1484. doi: 10.1016/j.jaip.2022.02.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2022.02.044</ArticleId><ArticleId IdType="pmc">PMC9009724</ArticleId><ArticleId IdType="pubmed">35431153</ArticleId></ArticleIdList></Reference><Reference><Citation>Subat YW, Hainy ME, Torgerud KD, et al. . Aerosol generation and mitigation during methacholine bronchoprovocation testing: infection control implications in the era of COVID-19. Respir Care 2021; 66: 1858–1865. doi: 10.4187/respcare.09236</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.09236</ArticleId><ArticleId IdType="pubmed">34789516</ArticleId></ArticleIdList></Reference><Reference><Citation>Culver BH, Graham BL, Coates AL, et al. . Recommendations for a standardized pulmonary function report. An official American Thoracic Society technical statement. Am J Respir Crit Care Med 2017; 196: 1463–1472.</Citation><ArticleIdList><ArticleId IdType="pubmed">29192835</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WT, Ko HK, Lin CC, et al. . Spirometric reference values in heathy Chinese adults in Taiwan: the secular changes and comparison with other Asian populations. J Formos Med Assoc 2020; 119: 290–299. doi: 10.1016/j.jfma.2019.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2019.05.015</ArticleId><ArticleId IdType="pubmed">31204144</ArticleId></ArticleIdList></Reference><Reference><Citation>Langan RC, Goodbred AJ. Office spirometry: indications and interpretation. Am Fam Physician 2020; 101: 362–368.</Citation><ArticleIdList><ArticleId IdType="pubmed">32163256</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Gammal AI, Killian KJ, Scime TX, et al. . Comparison of the provocative concentration of methacholine causing a 20% fall in FEV1 between the AeroEclipse II breath-actuated nebulizer and the Wright nebulizer in adult subjects with asthma. Ann Am Thorac Soc 2015; 12: 1039–1043. doi: 10.1513/AnnalsATS.201412-571BC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201412-571BC</ArticleId><ArticleId IdType="pubmed">25871542</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates AL, Wanger J, Cockcroft DW, et al. . ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J 2017; 49: 1601526. doi: 10.1183/13993003.01526-2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01526-2016</ArticleId><ArticleId IdType="pubmed">28461290</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Kim BG, Chung SJ, et al. . New-onset asthma following COVID-19 in adults. J Allergy Clin Immunol Pract 2023; 11: 2228–2231. doi: 10.1016/j.jaip.2023.03.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2023.03.050</ArticleId><ArticleId IdType="pmc">PMC10116152</ArticleId><ArticleId IdType="pubmed">37084939</ArticleId></ArticleIdList></Reference><Reference><Citation>Strazda G, Ieviņa M, Madaja O, et al. . Evaluation of bronchial hyperreactivity in patients after Covid-19 infection. Eur Respir J 2022; 60: Suppl. 66, 338. doi: 10.1183/13993003.congress-2022.338</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.congress-2022.338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DM, Seo JW, Kim Y, et al. . Eosinophil-mediated lung inflammation associated with elevated natural killer T cell response in COVID-19 patients. Korean J Intern Med 2022; 37: 201–209. doi: 10.3904/kjim.2021.093</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2021.093</ArticleId><ArticleId IdType="pmc">PMC8747909</ArticleId><ArticleId IdType="pubmed">34565131</ArticleId></ArticleIdList></Reference><Reference><Citation>Toh MR, Teo YR, Poh LCR, et al. . Impact of COVID infection on lung function test and quality of life. Sci Rep 2023; 13: 17275. doi: 10.1038/s41598-023-43710-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-43710-w</ArticleId><ArticleId IdType="pmc">PMC10570308</ArticleId><ArticleId IdType="pubmed">37828107</ArticleId></ArticleIdList></Reference><Reference><Citation>Caliskaner Ozturk B, Aykac EF, Vardaloglu I, et al. . Does mild coronavirus disease 2019 pneumonia in healthy adults cause permanent small airway injury? South Med J 2023; 116: 957–961. doi: 10.14423/smj.0000000000001626</Citation><ArticleIdList><ArticleId IdType="doi">10.14423/smj.0000000000001626</ArticleId><ArticleId IdType="pubmed">38051170</ArticleId></ArticleIdList></Reference><Reference><Citation>Peled M, Ovadya D, Cohn J, et al. . Baseline spirometry parameters as predictors of airway hyperreactivity in adults with suspected asthma. BMC Pulm Med 2021; 21: 153. doi: 10.1186/s12890-021-01506-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-021-01506-6</ArticleId><ArticleId IdType="pmc">PMC8101108</ArticleId><ArticleId IdType="pubmed">33957916</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Das S, Mondal R, et al. . A review on the effect of COVID-19 in type 2 asthma and its management. Int Immunopharmacol 2021; 91: 107309. doi: 10.1016/j.intimp.2020.107309</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107309</ArticleId><ArticleId IdType="pmc">PMC7772091</ArticleId><ArticleId IdType="pubmed">33385710</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Z, Chen Y, Wang Y, et al. . Immunometabolism in the pathogenesis of asthma. Immunology 2024; 171: 1–17. doi: 10.1111/imm.13688</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13688</ArticleId><ArticleId IdType="pubmed">37652466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Ding Y, Liu W, et al. . When AHR signaling pathways meet viral infections. Cell Commun Signal 2023; 21: 42. doi: 10.1186/s12964-023-01058-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-023-01058-8</ArticleId><ArticleId IdType="pmc">PMC9951170</ArticleId><ArticleId IdType="pubmed">36829212</ArticleId></ArticleIdList></Reference><Reference><Citation>Savin IA, Zenkova MA, Sen'kova AV. Bronchial asthma, airway remodeling and lung fibrosis as successive steps of one process. Int J Mol Sci 2023; 24: 16042. doi: 10.3390/ijms242216042</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms242216042</ArticleId><ArticleId IdType="pmc">PMC10671561</ArticleId><ArticleId IdType="pubmed">38003234</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>